Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Parallel Advisors LLC

Parallel Advisors LLC boosted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 447.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,394 shares of the health services provider's stock after buying an additional 5,225 shares during the quarter. Parallel Advisors LLC's holdings in Amedisys were worth $592,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Blue Trust Inc. raised its holdings in Amedisys by 55.1% in the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after acquiring an additional 124 shares during the last quarter. KBC Group NV raised its holdings in Amedisys by 76.8% in the 4th quarter. KBC Group NV now owns 1,158 shares of the health services provider's stock valued at $105,000 after acquiring an additional 503 shares during the last quarter. Calamos Advisors LLC raised its holdings in Amedisys by 22.7% in the 4th quarter. Calamos Advisors LLC now owns 487,444 shares of the health services provider's stock valued at $44,255,000 after acquiring an additional 90,097 shares during the last quarter. Retirement Systems of Alabama raised its holdings in Amedisys by 0.5% in the 4th quarter. Retirement Systems of Alabama now owns 39,822 shares of the health services provider's stock valued at $3,615,000 after acquiring an additional 181 shares during the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in Amedisys by 448.3% in the 4th quarter. State of Alaska Department of Revenue now owns 20,737 shares of the health services provider's stock valued at $1,882,000 after acquiring an additional 16,955 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Trading Up 0.0%

Shares of NASDAQ AMED traded up $0.01 during midday trading on Friday, reaching $93.89. 151,613 shares of the stock were exchanged, compared to its average volume of 408,989. Amedisys, Inc. has a twelve month low of $82.15 and a twelve month high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The company has a 50 day simple moving average of $93.64 and a 200 day simple moving average of $91.71. The stock has a market capitalization of $3.08 billion, a P/E ratio of 37.26, a PEG ratio of 1.78 and a beta of 0.94.

Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $594.78 million during the quarter, compared to the consensus estimate of $597.43 million. During the same quarter last year, the firm earned $1.03 EPS. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. As a group, equities analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have commented on AMED shares. Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. Royal Bank of Canada restated an "outperform" rating and set a $100.00 price target on shares of Amedisys in a report on Wednesday, April 16th. Finally, Stephens restated an "equal weight" rating and set a $101.00 price target on shares of Amedisys in a report on Tuesday, March 4th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.